SEC Form 10-K filed by Tenax Therapeutics Inc.
$TENX
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/24/2024 | $16.00 | Outperform | Leerink Partners |
| 10/14/2024 | $16.00 | Buy | Guggenheim |
| 9/30/2024 | Outperform | William Blair |
8-K - TENAX THERAPEUTICS, INC. (0000034956) (Filer)
10-Q - TENAX THERAPEUTICS, INC. (0000034956) (Filer)
8-K - TENAX THERAPEUTICS, INC. (0000034956) (Filer)